APA (7th ed.) Citation

R, C., M, R., V, C., S, L. V., & AE, C. (2025). Sodium-glucose cotransporter 2 inhibitors may increase iron availability with beneficial effects on erythropoiesis and cardiovascular mortality in patients with type 2 diabetes mellitus. Author's Reply. European journal of internal medicine, 141, 106516. https://doi.org/10.1016/j.ejim.2025.106516

Chicago Style (17th ed.) Citation

R, Cannarella, Rubulotta M, Cannarella V, La Vignera S, and Calogero AE. "Sodium-glucose Cotransporter 2 Inhibitors May Increase Iron Availability with Beneficial Effects on Erythropoiesis and Cardiovascular Mortality in Patients with Type 2 Diabetes Mellitus. Author's Reply." European Journal of Internal Medicine 141 (2025): 106516. https://doi.org/10.1016/j.ejim.2025.106516.

MLA (9th ed.) Citation

R, Cannarella, et al. "Sodium-glucose Cotransporter 2 Inhibitors May Increase Iron Availability with Beneficial Effects on Erythropoiesis and Cardiovascular Mortality in Patients with Type 2 Diabetes Mellitus. Author's Reply." European Journal of Internal Medicine, vol. 141, 2025, p. 106516, https://doi.org/10.1016/j.ejim.2025.106516.